ORCHID PHARMA
Back to Cashflow Statement
|
ORCHID PHARMA Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹25 Cr | ₹167 Cr | ₹31 Cr | ₹-217 Cr | ₹-165 Cr |
What is the latest Cash Flow from Financing Activities ratio of ORCHID PHARMA ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹25 Cr |
| Mar2024 | ₹167 Cr |
| Mar2023 | ₹31 Cr |
| Mar2022 | ₹-217 Cr |
| Mar2021 | ₹-165 Cr |
How is Cash Flow from Financing Activities of ORCHID PHARMA Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹25 Cr | -84.90 | |
| Mar2024 | ₹167 Cr | 435.97 | |
| Mar2023 | ₹31 Cr | Positive | |
| Mar2022 | ₹-217 Cr | Negative | |
| Mar2021 | ₹-165 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ORCHID PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ORCHID PHARMA | ₹5,820.8 Cr | -0.5% | -1.4% | 37% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,025.9 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
ORCHID PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ORCHID PHARMA | -0.5% |
-1.4% |
37% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses